Mitchell Sinkler & Starr Johnson & Johnson Transaction History

Mitchell Sinkler & Starr

$422 Million
Q3 2024

A detailed history of Mitchell Sinkler & Starr transactions in Johnson & Johnson stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 85,371 shares of JNJ stock, worth $12.3 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares

85,371

Previous 77,783 9.76%

Holding current value

$12.3 Million

Previous $11.4 Million 21.7%

% of portfolio

3.28%

Previous 2.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $1.1 Million - $1.27 Million	7,588 Added 9.76%	85,371 $13.8 Million
Q2 2024 Aug 07, 2024	SELL	$144.38 - $157.78 $159,251 - $174,031	-1,103 Reduced 1.4%	77,783 $11.4 Million
Q1 2024 Apr 30, 2024	SELL	$155.22 - $162.74 $8.55 Million - $8.97 Million	-55,101 Reduced 41.12%	78,886 $12.5 Million
Q4 2023 Feb 12, 2024	BUY	$145.6 - $158.88 $5.08 Million - $5.54 Million	34,888 Added 35.21%	133,987 $21 Million
Q3 2023 Nov 01, 2023	BUY	$155.75 - $174.48 $2.75 Million - $3.08 Million	17,642 Added 21.66%	99,099 $15.4 Million
Q2 2023 Jul 18, 2023	SELL	$154.35 - $166.11 $3,087 - $3,322	-20 Reduced 0.02%	81,457 $13.5 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $1.43 Million - $1.7 Million	9,449 Added 13.12%	81,477 $12.6 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $416,039 - $466,914	2,597 Added 3.74%	72,028 $12.7 Million
Q3 2022 Oct 25, 2022	BUY	$161.33 - $179.52 $351,699 - $391,353	2,180 Added 3.24%	69,431 $11.3 Million
Q2 2022 Jul 21, 2022	BUY	$168.19 - $186.01 $113,023 - $124,998	672 Added 1.01%	67,251 $11.9 Million
Q1 2022 Apr 19, 2022	BUY	$158.14 - $179.59 $55,032 - $62,497	348 Added 0.53%	66,579 $11.8 Million
Q4 2021 Feb 01, 2022	BUY	$155.93 - $173.01 $7.96 Million - $8.83 Million	51,030 Added 335.7%	66,231 $11.3 Million
Q3 2021 Oct 12, 2021	SELL	$161.5 - $179.47 $29,070 - $32,304	-180 Reduced 1.17%	15,201 $2.46 Million
Q2 2021 Jul 15, 2021	SELL	$159.48 - $171.07 $30,301 - $32,503	-190 Reduced 1.22%	15,381 $2.53 Million
Q1 2021 Apr 12, 2021	SELL	$153.07 - $170.48 $355,275 - $395,684	-2,321 Reduced 12.97%	15,571 $2.56 Million
Q4 2020 Feb 09, 2021	SELL	$137.11 - $157.38 $171,661 - $197,039	-1,252 Reduced 6.54%	17,892 $2.82 Million
Q3 2020 Oct 07, 2020	BUY	$140.38 - $153.83 $131,255 - $143,831	935 Added 5.13%	19,144 $2.85 Million
Q2 2020 Jul 20, 2020	BUY	$128.81 - $155.51 $1,288 - $1,555	10 Added 0.05%	18,209 $2.56 Million
Q1 2020 Apr 07, 2020	SELL	$111.14 - $153.99 $57,792 - $80,074	-520 Reduced 2.78%	18,199 $2.39 Million
Q4 2019 Jan 09, 2020	BUY	$127.5 - $146.44 $347,437 - $399,049	2,725 Added 17.04%	18,719 $2.73 Million
Q3 2019 Nov 06, 2019	SELL	$126.95 - $142.14 $37,958 - $42,499	-299 Reduced 1.84%	15,994 $2.07 Million
Q2 2019 Jul 17, 2019	SELL	$131.15 - $144.24 $3,278 - $3,606	-25 Reduced 0.15%	16,293 $2.27 Million
Q1 2019 Apr 08, 2019	SELL	$125.72 - $139.79 $110,507 - $122,875	-879 Reduced 5.11%	16,318 $2.28 Million
Q4 2018 Jan 24, 2019	SELL	$122.84 - $147.84 $25,182 - $30,307	-205 Reduced 1.18%	17,197 $2.22 Million
Q3 2018 Oct 04, 2018	SELL	$121.58 - $142.88 $72,948 - $85,728	-600 Reduced 3.33%	17,402 $2.4 Million
Q2 2018 Jul 11, 2018	SELL	$119.4 - $131.76 $36,775 - $40,582	-308 Reduced 1.68%	18,002 $2.18 Million
Q1 2018 Apr 13, 2018	SELL	$125.1 - $148.14 $53,167 - $62,959	-425 Reduced 2.27%	18,310 $2.35 Million
Q4 2017 Jan 11, 2018	SELL	$131.22 - $143.62 $9,185 - $10,053	-70 Reduced 0.37%	18,735 $2.62 Million
Q3 2017 Oct 23, 2017	BUY	$129.47 - $135.38 $2.43 Million - $2.55 Million	18,805	18,805 $2.45 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Account

Mitchell Sinkler & Starr Johnson & Johnson Transaction History